Log In
Print
BCIQ
Print
Print this Print this
 

RP-G28

  Manage Alerts
Collapse Summary General Information
Company Ritter Pharmaceuticals Inc.
DescriptionShort chain oligosaccharide used to stimulate colonic growth of lactose-fermenting bacteria in the large intestine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Gastrointestinal (unspecified)
Indication DetailsImprove digestive symptoms associated with lactose intolerance; Treat lactose intolerance
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today